Clinical Challenges in the Infected Diabetic Foot:
Methicillin-Resistant Staphylococcus Aureus

Virtual Activity

Jointly sponsored by the University of Cincinnati and North American Center for Continuing Medical Education, LLC

Powered by RealCME, Inc.

Inpatient Virtual Activity

Chair

Robert G. Frykberg, DPM, MPH
Chief, Podiatry
Residency Director
Carl T. Hayden VA Medical Center
Phoenix, Arizona

Commentator

Warren S. Joseph, DPM, FIDSA
Podiatric Attending
Roxborough Memorial Hospital
Philadelphia, Pennsylvania

Outpatient Virtual Activity

Chair

John G. Fleischli, DPM, FACFAS
Podiatrist
Foot and Ankle Associates of Central Illinois
Jacksonville, Illinois

Commentator

Lawrence Lavery, DPM, MPH
Professor of Surgery
Podiatric Medicine and Surgery
Texas A&M Health Science Center College of Medicine
Scott & White Hospital
Temple, Texas

Target Audience

This activity is designed for podiatrists and other physicians who manage patients with MRSA in the diabetic foot.

Learning Objectives

After completion of this activity, participants should be able to:

• Assess the patient with MRSA-related diabetic foot infection, including use of culturing techniques to guide antibiotic selection
• Compare and contrast the safety and efficacy of available antibiotics for the management of MRSA in the diabetic foot
• Implement evidence-based and patient-centered management of MRSA in the diabetic foot to improve outcomes
• Institute infection-control measures in the practice setting

Activity Overview

Each virtual patient activity consists of 2 patient visits of 0.5 credits each. Physicians can earn 0.5 AMA PRA Category 1 Credits^TM per patient visit. Podiatrists must complete 2 patient visits to earn 1 continuing education contact hour.

To be eligible for documentation of credit, participants must participate in the entire patient visit, complete the 5-question post-test with a score of 80% or better, and complete the evaluation form. Participants who successfully complete the post-test and evaluation form online may immediately print their documentation of credit.

For questions regarding this educational activity, please contact Angela Scarnici at 609-371-1137.

Release Date: December 22, 2009

Expiration Date:  December 22, 2010

Estimated time to complete: 0.5 hours per patient visit

There is no fee associated with this activity.

CME Accreditation

The University of Cincinnati is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The University of Cincinnati designates each virtual patient case visit for a maximum of 0.5 AMA PRA Category 1 Credits^TM. Physicians should only claim credit commensurate with the extent of their participation in the activity.

CPME Accreditation

North American Center for Continuing Medical Education, LLC (NACCME) is approved by the Council on Podiatric Medical Education as a sponsor of continuing education in podiatric medicine.

Each virtual activity is approved for 1 continuing education contact hour or 0.1 CEU.

Partial credit is not available for podiatrists for this activity. For a statement of credit to be issued, each 1-hour activity must be completed in its entirety.

Independent Clinical Reviewer: Michael Radzienda, MD, Assistant Professor and Chief, Section of Hospital Medicine, Medical College of Wisconsin, Milwaukee, WI

Hardware/Software Requirements

All educational activities are accessible via a computer with 650 MHz PC, 128 MB RAM, Windows or MAC operating system, Internet Explorer (v6 or greater), Netscape or Safari browsers. Windows Media Player, sound card, and speakers are required for streamed audio. Flash Player, sound card, and speakers are required for video programs. A PDF reader is required for print publications. Please direct technical questions to webmaster@naccme.com.

Planning Committee

The planning committee comprises John Fleischli, DPM, Robert G. Frykberg, DPM, MPH, Lawrence Lavery, DPM, MPH, Warren S. Joseph, DPM, FIDSA; Michael Radzienda, MD; Kay Weigand, University of Cincinnati; Rosemary Hodgson, Emilie McCardell, Tiffney Oliver, Randy Robbin, John Savage, and Richard Michael Tyska, PharmD, NACCME.

Financial Disclosures and Conflicts of Interest

According to the disclosure policy of the University of Cincinnati and NACCME, faculty, editors, managers, and other individuals who are in a position to control content are required to disclose any relevant financial relationships with relevant commercial companies related to this activity.  All relevant conflicts of interest that are identified are reviewed for potential conflicts of interest.  If a conflict is identified, it is the responsibility of the University of Cincinnati and NACCME to initiate a mechanism to resolve the conflict(s). The existence of these interests or relationships is not viewed as implying bias or decreasing the value of the presentation.
                    
All educational materials are reviewed for fair balance, scientific objectivity of studies reported, and levels of evidence.

The faculty has reported the following:
Dr. Fleischli: Grant/Research Support—Arthrex, Inc., Acumed LLC, Mast Biosurgery; Scientific Advisor— Pegasus Biologic, Inc.; Promotional Speakers’ Bureau—Pfizer Inc; Shareholder/Stock Options—Pfizer Inc
Dr. Frykberg: Grant/Research Support—Advanced Biohealing, Inc., SANUWAVE, Inc.; Consultant— Regenesis Biomedical, Inc.; Scientific Advisor— Advanced Biohealing, Inc., Regenesis Biomedical, Inc.; Promotional Speakers’ Bureau—Advanced Biohealing, Inc., Healthpoint, Ltd.
Dr. Lavery: Grant/Research Support— Advanced Biohealing, Inc., Kinetic Concepts, Inc., Smith & Nephew; Scientific Advisor—Diabetica Solutions Inc., National Healing Corporation, Cytomedica; Promotional Speakers’ Bureau—Advanced Biohealing, Inc., Kinetic Concepts, Inc., National Healing Corporation; Shareholder/Stock Options—Diabetica Solutions Inc.; Employee/Officer/Board Member—Diabetica Solutions Inc.
Dr. Joseph: Scientific Advisor—Pfizer Inc; Promotional Speakers’ Bureau—Merck & CO., Inc., Pfizer Inc
Dr. Radzienda: Has disclosed no relevant financial relationships with any commercial interest

Ms. Hodgson, Ms. McCardell, Ms. Oliver, Mr. Robbin, Mr. Savage, Dr. Tyska, and Ms. Weigand have disclosed no relevant financial relationships with any commercial interest.

The University of Cincinnati and NACCME require faculty to inform participants whenever off-label/unapproved uses of drugs and/or devices are discussed in their presentations.

The faculty has disclosed that no off-label/unapproved use(s) of drugs and/or devices will be discussed.

Privacy Policy

NACCME protects the privacy of personal and other information regarding participants, educational partners, and joint sponsors. NACCME and our joint sponsors will not release personally identifiable information to a third party without the individual's consent, except such information as is required for reporting purposes to the appropriate accrediting agency.

NACCME maintains physical, electronic, and procedural safeguards that comply with federal regulations to guard your nonpublic personal information.

Copyright © 2009 by North American Center for Continuing Medical Education, LLC. All rights reserved. No part of this accredited continuing education activity may be reproduced or transmitted in any form or by any means, electronic or mechanical, without first obtaining permission from North American Center for Continuing Medical Education.

Grant Support

Supported by educational grants from Pfizer and Astellas